These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Human growth hormone in urine: development of an ultrasensitive radiometric assay. Erb T; Karolyi G; Pampalone A; Eberle AN; Baumann JB; Bürgisser E; Girard J Experientia; 1988 Feb; 44(2):155-7. PubMed ID: 3345820 [TBL] [Abstract][Full Text] [Related]
44. [Clinical usefulness of the determination of urinary growth hormone]. Bernardini S; Spadoni GL; Boscherini B Minerva Pediatr; 1990; 42(7-8):267-71. PubMed ID: 2274003 [No Abstract] [Full Text] [Related]
45. Quantitative polyacrylamide gel electrophoresis and specific activities of human somatotropin and its derivatives. Skyler JS; Chrambach A; Li CH Biochim Biophys Acta; 1977 Apr; 491(2):566-72. PubMed ID: 870069 [TBL] [Abstract][Full Text] [Related]
46. Monoclonal antibody-mediated enhancement of growth hormone activity in vivo. Holder AT; Aston R; Preece MA; Ivanyi J J Endocrinol; 1985 Dec; 107(3):R9-12. PubMed ID: 4067484 [TBL] [Abstract][Full Text] [Related]
48. The biological half-life of human growth hormone and a biologically active 20,000-dalton variant in mouse blood. Sigel MB; VanderLaan WP; Kobrin MS; VanderLaan EF; Thorpe NA Endocr Res Commun; 1982; 9(1):67-77. PubMed ID: 7094874 [TBL] [Abstract][Full Text] [Related]
49. [Determination of human growth hormone with solid phase radioimmunoassay]. Furuno K; Ogawa N; Takahara J; Ofuji M Horumon To Rinsho; 1973 Dec; 21(12):1285-8. PubMed ID: 4798495 [No Abstract] [Full Text] [Related]
51. Use of sheep erythrocytes as solid phase supports in double antibody immunoassay systems. Kane J; Gowland E J Clin Pathol; 1979 Feb; 32(2):193-5. PubMed ID: 571442 [No Abstract] [Full Text] [Related]
52. [Monoclonal antibodies: applications to endocrinological research in vitro and in vivo]. Simionescu L Endocrinologie; 1986; 24(2):133-7. PubMed ID: 3738403 [No Abstract] [Full Text] [Related]
54. Scientific and regulatory considerations in the development of human growth factors. Fleming GA; Jordan AW; Chiu YY Bioprocess Technol; 1991; 13():341-54. PubMed ID: 1367138 [No Abstract] [Full Text] [Related]
55. [Statistical analysis of radioimmunoassay--in comparison with bioassay]. Nakano R Horumon To Rinsho; 1973 Jan; 21(1):53-7. PubMed ID: 4736416 [No Abstract] [Full Text] [Related]
57. Biological methods for determination of potency of growth hormone preparations. KEMP T Acta Endocrinol (Copenh); 1948; 1(3):294-8. PubMed ID: 18892098 [No Abstract] [Full Text] [Related]
58. Comparative potency of growth hormone preparations in alkali or acid. LAZO-WASEM EA; GRAHAM CE Endocrinology; 1958 Feb; 62(2):108-11. PubMed ID: 13501179 [No Abstract] [Full Text] [Related]
59. On the accuracy of methods for determining the potency of growth hormone preparations. GJEDDEBAEK NF Acta Endocrinol (Copenh); 1948; 1(3):258-62. PubMed ID: 18892094 [No Abstract] [Full Text] [Related]
60. The assay of testicular hormone preparations. Korenchevsky V Biochem J; 1932; 26(2):413-22. PubMed ID: 16744839 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]